Marketing & Strategy
PRIME Awards 2023 finalists announced
The finalists for PRIME Awards 2023 have been named, with winners to be announced on Thursday the 9th November at the Sofitel Sydney Wentworth.
From the highest number of submissions in the history of PRIME, 55 entries have been successfully shortlisted by a joint panel of 26 judges across marketing, public relations, education, public health, and pharmaceutical sales.
Chair of Judges, David Cousins, said PRIME Awards continues to go from strength to strength with 2023 a record year for entries.
“In this context the commitment from our judges is incredible and I thank them for their ethical, objective, and thorough approach,” said Mr Cousins.
“Even after two rounds of online scoring, the quality of entries this year meant every category was highly competitive, making decisions for our finalist judges extremely challenging. Congratulations to everyone who entered.”
The complete list of finalists can be viewed via the PRIME Awards website. Tickets for the ceremony are now on sale.
PRIME Awards recognises and celebrates excellence within healthcare communications in the pharmaceutical and life sciences industry. Health Industry Hub is the media partner for the event.
In reimagining healthcare, Health Industry HubTM is the ONLY one-stop-hub uniting the diversity of Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change. The exclusive leadership and influencer podcasts and vodcasts offer unparalleled insights and add immense value to our breaking news coverage.
The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.
News & Trends - Pharmaceuticals
Roche’s immunotherapy drug shows promising results for Australian patients with rare blood cancer
Pharma News: Roche’s immunotherapy drug has shown high response rates in patients with a rare form of blood cancer that […]
MoreNews & Trends - Pharmaceuticals
Government seals deal with industry for rare cancer therapy
Pharma News: Australian children and young adults diagnosed with high-risk neuroblastoma will continue to receive free access to a promising, […]
MoreNews & Trends - MedTech & Diagnostics
Abbott showcases leadless pacemaker system to local stakeholders
MedTech & Diagnostics News: Leadless pacemakers are promising alternatives to transvenous pacing. Abbott hosted a stakeholder event at the recent […]
MoreNews & Trends - Pharmaceuticals
Australian scientists pivotal in new drug class from BMS
Pharma News: The first new class of drug for schizophrenia in decades has been approved, offering a fresh approach by […]
More